A new web
on its way.
Stay tuned for the evolution to
Takeda Oncology 1Point.
If you have concerns about paying for your multiple myeloma treatment, then this section has the resources you need. From financial assistance programs to information about specialty pharmacies, we're committed to helping you get the treatment you need.
Learn more about the services designed to help you access and pay for treatment.
At Takeda Oncology, we are committed to helping you get access to NINLARO® (ixazomib) whenever possible. NINLARO 1Point offers comprehensive programs that can assist with the financial concern, cost, and other day-to-day needs associated with your NINLARO treatment.
Your healthcare team can help you submit a NINLARO 1Point enrollment form. To enroll, you will need to submit a completed enrollment form and a valid prescription for NINLARO.
If you have private insurance but are concerned about your ability to pay for NINLARO, you may qualify for the NINLARO Co-pay Assistance Program. See eligibility requirements.*†
Please visit www.NINLAROcopay.com to enroll. You can also use this site to re-enroll, activate your card, or request a replacement card. You may also enroll in this program by contacting NINLARO 1Point at 1-844-617-6468, as well as through your designated specialty pharmacy or your doctor.
The NINLARO RapidStart Program can provide a 1-cycle (the number of pills prescribed in a 28-day period) supply of NINLARO® (ixazomib) for patients who experience a delay in insurance coverage determination of at least 7 business days. NINLARO terms and conditions apply.*
To receive a 1-cycle supply (28-day supply of treatment), speak with your doctor or nurse. Your healthcare team must submit a completed NINLARO 1Point enrollment form and a valid prescription.
Takeda Oncology remains committed to helping you gain access to treatment. NINLARO 1Point can help with identifying alternative and supplemental insurance coverage options. In addition, the NINLARO Patient Assistance Program may be able to provide free medication to eligible patients who do not have prescription drug or health insurance coverage. If you qualify for the program, NINLARO® (ixazomib) will be delivered to you free of charge.
To apply for the Patient Assistance Program, ask your healthcare team to submit a completed and signed Patient Assistance Program Application‡ and a valid prescription for NINLARO. Be sure to also sign the form and submit the required household verification.
If you are approved for this program, you and your doctor will be notified and a 1-month supply of NINLARO will be mailed to you. Please note that each month, your doctor's office must confirm that you are still being treated with NINLARO and require another month's supply.
If you qualify, you may be enrolled for up to 1 year.
Whether it's finding resources, helping you with financial assistance for treatment, or coordinating delivery of NINLARO® (ixazomib) from a specialty pharmacy to your home, NINLARO 1Point can connect you to a range of personal support services.
Support & resources include:
The Empower Program provides personalized education and support for people who are taking NINLARO. Receive personal, ongoing support and educational resources from your Adherence Clinical Educator (ACE). Learn more about Empower.
Specialty pharmacies may help you with:
When your doctor prescribes an oral (or capsule) form of a medicine, a specialty pharmacy helps you get your medicine. Specialty pharmacies provide coordinated delivery of your medicine to you.
NINLARO 1Point helps to identify third-party nonprofit foundations that can grant financial assistance if you struggle with your out-of-pocket treatment-related expenses (eg, co-pays, coinsurance, and deductibles).
The foundations and online resource directories below offer support to patients with cancer in need of financial assistance.
Patient Advocate Foundation
Patient Access Network Foundation
Leukemia and Lymphoma Society
Multiple Myeloma Research Foundation
International Myeloma Foundation
Patient Advocate Foundation
*Patient eligibility varies by program.